引用本文:
【打印本页】   【下载PDF全文】   View/Add Comment  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 4555次   下载 2991 本文二维码信息
码上扫一扫!
分享到: 微信 更多
纤溶酶原激活物抑制剂-1与肾间质纤维化
刘艳红(综述),韩子明(审校)
450000 河南,郑州人民医院新生儿科(刘艳红);453100 河南,新乡医学院第一临床医院儿内二科(韩子明)
摘要:
[摘要] 肾间质纤维化(RIF)是各种慢性肾脏疾病发展到终末期肾病的共同归路。纤溶酶原激活物抑制剂(PAI)的表达及活性异常在RIF病变中发挥着至关重要的作用。该文就PAIs系统在RIF发生发展过程中的作用做一综述。
关键词:  肾间质纤维化  纤溶酶原激活物  纤溶酶原激活物抑制剂-1  细胞外基质
DOI:10.3969/j.issn.1674-3806.2011.01.37
分类号:R 692
基金项目:
Plasminogen activator inhibitor and renal interstitial fibrosis
LIU Yan-hong,HAN Zi-ming
Department of Neonatology, Zhengzhou People′s Hospital, Henan 450000,China
Abstract:
[Abstract] Renal interstitial fibrosis(RIF)is the final common pathway by which all kidney diseases progress to the end stage of renal disease.Present study confirmed that the expression and abnormal activity of plasminogen activator inhibitor (PAI)play a vital role in the development process of RIF.This is a review of the role of PAI in the development process of RIF.
Key words:  Renal interstitial fibrosis  Plasminogen activator inhibitor  Extracelluar matrix